Cargando…
Exploiting the biological effect exerted by lipid nanocapsules in non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) affects approximately 25% of the global adult population and can progress to end-stage liver disease with life-threatening complications; however, no pharmacologic therapy has been approved. Drug delivery systems such as lipid nanocapsules (LNCs) are a very...
Autores principales: | Domingues, Inês, Michalowski, Cecilia Bohns, Marotti, Valentina, Zhang, Wunan, Van Hul, Matthias, Cani, Patrice D., Leclercq, Isabelle A., Beloqui, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614370/ https://www.ncbi.nlm.nih.gov/pubmed/36907563 http://dx.doi.org/10.1016/j.jconrel.2023.03.012 |
Ejemplares similares
-
A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment
por: Marotti, Valentina, et al.
Publicado: (2023) -
Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment
por: Zhang, Wunan, et al.
Publicado: (2021) -
Novel strategy for oral peptide delivery in incretin-based diabetes treatment
por: Xu, Yining, et al.
Publicado: (2020) -
Mediterranean diet, gut microbiota and health: when age and calories do not add up!
por: Cani, Patrice D, et al.
Publicado: (2020) -
Targeting Carbohydrates and Polyphenols for a Healthy Microbiome and Healthy Weight
por: Van Hul, Matthias, et al.
Publicado: (2019)